Prospective, controlled follow-up observation of SARS-CoV-2 positive patients with regard to the aspect of fatigue (cognitive / motor) and psychological disorders in the areas of anxiety, depression and somatization.
After informed consent is given, questionnaires will be obtained 6 months and 12 months after infection. For analyzing cognitive and motor fatigue, classified in mildly, moderately or severely fatigue the questionnaire will be calculated by The Fatigue Scale for Motor and Cognitive Functions (FSMC). And the occurrence of Major Depressive Disorder, other depressive Syndrome or Panic syndrome measured by Brief Patient Health Questionnaire. The FSC19-KN trial already included patients with positive test for SARS-CoV-2 by PCR and volunteers with negative SARS-CoV-2 antibody testing. Verification of exclusion criteria had been completed in the main trial FSC19-KN. After the informed consent to participation in the sub-study is given all inclusion modalities are fulfilled.
Study Type
OBSERVATIONAL
Enrollment
353
Fulfilling Questionaires PHQ-D (brief) and FSMC
Hegau Bodensee Klinikum Singen
Singen, Baden-Wurttemberg, Germany
Presence of fatigue
Evaluate cognitive and motor fatigue classified in mildly, moderately or severely fatigue
Time frame: 6 month after infection
Presence of fatigue
Evaluate cognitive and motor fatigue classified in mildly, moderately or severely fatigue
Time frame: 12 month after infection
Occurrence of Major Depressive Disorder, other depressive Syndrome or Panic syndrome.
analyzed by PHQ-D (brief)
Time frame: 6 month after infection
Occurrence of Major Depressive Disorder, other depressive Syndrome or Panic syndrome.
analyzed by PHQ-D (brief)
Time frame: 12 month after infection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.